Therefore, direct protection of cardiovascular system and favorable effects on multiple cardiovascular risk factors (hyperglycemia, blood pressure, dyslipidemia, body weight) observed in patients receiving GLP-1RAs may provide an explanation for the cardiovascular benefits of GLP-1RAs (Fig
As mentioned above, DPP-4 inhibitors can increase endogenous GLP-1 levels by suppressing GLP-1 degradation
The harder you push, the harder your biology pushes back, and this cycle leaves millions of men feeling like their genetics have sentenced them to carry excess weight forever
BMI of 30 or Higher Adults with a BMI of 30 or higher may be considered for prescription weight management after a medical evaluation
Verma S, Goldenberg RM, Bhatt DL, Farkouh ME, Quan A, Teoh H, Connelly KA, Leiter LA, Friedrich JO